β-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1β- and tumor necrosis factor-α (TNFα)-dependent, and involves a TNFα receptor-associated factor- and NFκB-inducing kinase-dependent signaling mechanism

被引:303
作者
Akama, KT
Van Eldik, LJ
机构
[1] Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA
[2] Northwestern Univ, Sch Med, Northwestern Drug Discovery Program, Chicago, IL 60611 USA
关键词
D O I
10.1074/jbc.275.11.7918
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In Alzheimer's disease, beta-amyloid (AP) plaques are surrounded by activated astrocytes and microglia, A growing body of evidence suggests that these activated glia contribute to neurotoxicity through the induction of inflammatory cytokines such as interleukin (IL)-1 beta and tumor necrosis factor-ac (TNF alpha) and the production of neurotoxic free radicals, mediated in part by the expression of inducible nitric-oxide synthase (iNOS). Here, we address the possibility that A beta-stimulated iNOS expression might result from an initial induction of IL-1 beta and TNF alpha. We find that in A beta-stimulated astrocyte cultures, IL-1 beta and TNF alpha production occur before iNOS production, new protein synthesis is required for increased iNOS mRNA levels, and the IL-I receptor antagonist IL-1 beta can inhibit nitrite accumulation. Likewise, dominant-negative mutants of tumor necrosis factor-alpha receptor-associated factor (TRAF) 6, TRAF2, and NF kappa B-inducing kinase (NIK), intracellular proteins involved in IL-I and TNF alpha! receptor signaling cascades, inhibit A beta-stimulated iNOS promoter activity. Our data suggest that A beta stimulation of astrocyte iNOS is mediated in part by IL-1 beta and TNF alpha, and involves a TRAFG-, TRAF2-, and NIK-dependent signaling mechanism.
引用
收藏
页码:7918 / 7924
页数:7
相关论文
共 60 条
  • [21] Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury
    Friedlander, RM
    Gagliardini, V
    Hara, H
    Fink, KB
    Li, WW
    MacDonald, G
    Fishman, MC
    Greenberg, AH
    Moskowitz, MA
    Yuan, JY
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (05) : 933 - 940
  • [22] Molecular biology of nitric oxide synthases
    Geller, DA
    Billiar, TR
    [J]. CANCER AND METASTASIS REVIEWS, 1998, 17 (01) : 7 - 23
  • [23] GRIFFIN WST, 1993, ALTSCHUL SY, V2, P359
  • [24] Griffin WST, 1998, BRAIN PATHOL, V8, P65
  • [25] p38 kinase is activated in the Alzheimer's disease brain
    Hensley, K
    Floyd, RA
    Zheng, NY
    Nael, R
    Robinson, KA
    Nguyen, X
    Pye, QN
    Stewart, CA
    Geddes, J
    Markesbery, WR
    Patel, E
    Johnson, GVW
    Bing, GY
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 72 (05) : 2053 - 2058
  • [26] Amyloid-β peptide activates cultured astrocytes:: morphological alterations, cytokine induction and nitric oxide release
    Hu, JG
    Akama, KT
    Krafft, GA
    Chromy, BA
    Van Eldik, LJ
    [J]. BRAIN RESEARCH, 1998, 785 (02) : 195 - 206
  • [27] Hu JR, 1997, J NEUROCHEM, V69, P2294
  • [28] Iadecola C, 1997, J NEUROSCI, V17, P9157
  • [29] Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region
    Ishida, T
    Mizushima, S
    Azuma, S
    Kobayashi, N
    Tojo, T
    Suzuki, K
    Aizawa, S
    Watanabe, T
    Mosialos, G
    Kieff, E
    Yamamoto, T
    Inoue, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) : 28745 - 28748
  • [30] Jobin C, 1999, J IMMUNOL, V162, P4447